Journal article

The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study

Andrew J Cowan, Helen Baldomero, Yoshiko Atsuta, Joseph Mikhael, Mahmoud Aljurf, Adriana Seber, Hildegard Greinix, Mickey Koh, Nina Worel, Edward N Libby, Marcelo Pasquini, Sebastian Galeano, Wael Saber, Minako Iida, Gregorio Jaimovich, Juliana Martinez Rolon, Yoshihisa Kodera, Malek Benakli, Bazuaye G Nosa, Alaa Elhaddad Show all

Biology of Blood and Marrow Transplantation | ELSEVIER SCIENCE INC | Published : 2020


Multiple myeloma (MM) is a plasma cell neoplasm characterized by destructive bony lesions, anemia, and renal impairment. Access to effective therapy is limited globally. We report the rates and utilization of hematopoietic cell transplantation (HCT) globally from 2006-2015 to better characterize access to HCT for patients with MM. This was an analysis of a retrospective survey of Worldwide Network of Blood and Marrow Transplant sites, conducted annually between 2006-2015. Incidence estimates were from the Global Burden of Disease study. Outcome measures included total number of autologous and allogeneic HCTs by world regions, and percentage of newly diagnosed MM patients who underwent HCT, c..

View full abstract


Funding Acknowledgements

Andrew J Cowan: Consulting from Janssen. Advisory Board from Cellectar, Sanofi-Aventis. Research Funding from Bristol Myers Squibb, Janssen, AbbVie, Nektar